Researchers at BC Children’s Hospital (BCCH) and the University of British Columbia have found a new sub-type of inflammatory bowel disease (IBD) that can be treated with existing drugs that target the body’s inflammatory response. This discovery may help children who have been diagnosed with Crohn’s disease but aren’t responding to current treatments.
Lead
Researchers with the Immunity in Health & Disease Group are focused on improving our understanding of healthy immune responses and how the immune system contributes to immune-mediated diseases in children.
